Rhinovirus Resilience Amidst COVID-19
Study reveals the ongoing impact of rhinoviruses during the pandemic.
― 4 min read
Table of Contents
- Characteristics of Rhinoviruses
- Epidemiology of Rhinovirus Infections
- Study Overview
- Data Collection
- Demographic Information
- Seasonal Variations
- Comparison of Different Time Periods
- Genotype Diversity
- Changes Over Time
- Geographic Spread
- Recombination Events
- Implications for Vaccine Development
- Clinical Significance
- Conclusion
- Original Source
- Reference Links
Human Rhinoviruses (RV) are a major cause of the common cold and are responsible for a significant number of upper respiratory infections. These viruses can lead to various symptoms and conditions, including asthma attacks and respiratory issues in people with weakened immune systems. Despite being widespread, knowledge about RV is limited compared to other viruses like influenza.
Characteristics of Rhinoviruses
Rhinoviruses are small viruses that have a simple genetic makeup. Their genome consists of a single strand of RNA that is approximately 7,300 nucleotides long. This RNA is arranged in a way that allows the virus to produce proteins necessary for its structure and function. To date, scientists have identified over 100 different types of RV, which complicates efforts to develop vaccines.
Epidemiology of Rhinovirus Infections
Recent studies conducted in specific regions showed that a notable percentage of people with upper respiratory infections were infected with RV. For example, a large number of RV positive cases were observed during the COVID-19 pandemic, indicating that RV remained active even when other respiratory viruses were being monitored.
Study Overview
Research was conducted to track the spread and evolution of RV infections using a collection of over a thousand RV genomes. This study took place in the Puget Sound area of Washington State, focusing on two separate periods during the pandemic.
Data Collection
The data was gathered from nasal swabs of people who were tested for COVID-19 but were found to be negative. The samples were collected from community testing sites across a range of dates in 2021 and 2022. Analysis indicated that many of those who tested positive for RV were experiencing symptoms commonly associated with respiratory infections.
Demographic Information
Among those with RV infections, many were adults aged 18 to 65. Interestingly, children aged 5 to 17 had lower amounts of the virus in their systems compared to older individuals. Most RV-positive individuals displayed symptoms such as cough, sore throat, and runny nose, indicating that the virus can lead to noticeable health issues.
Seasonal Variations
The study observed seasonal patterns in the occurrence of RV. There were higher levels of RV cases in the spring and summer, while other types of respiratory viruses, like RSV and influenza, became more prominent during the fall and winter months.
Comparison of Different Time Periods
Data showed a clear distinction in virus circulation between the two studied periods. The first period saw a low rate of other respiratory viruses alongside RV, while the second period experienced a significant rise in other viruses. This shift highlighted the changing landscape of respiratory infections over time.
Genotype Diversity
The research also aimed to understand the variety of RV genotypes present in the Puget Sound area. A total of 1,003 complete or nearly complete RV genomes were successfully sequenced. This included various types of RV, showing a complex network of different strains circulating within the population.
Changes Over Time
The researchers noted changes in which RV genotypes were more common from one time period to the next. Some genotypes were more prevalent in the spring, while others showed up more frequently in the fall. This suggests an evolving pattern in the types of rhinoviruses that are affecting the population.
Geographic Spread
The study looked into whether the RV infections varied by location within the Puget Sound area. The findings indicated that there was no significant difference in which types of RV were present depending on where the samples were collected. This suggests that the viruses were widely distributed across the entire region.
Recombination Events
An interesting discovery was made regarding gene mixing, or recombination, between different strains of RV. This phenomenon can affect how the virus behaves and how it interacts with the immune system. In particular, a specific combination of genetic material from two RV types was identified, indicating that such events are likely occurring in nature.
Implications for Vaccine Development
The findings of the study raise important questions about future vaccine development. Given the variety of RV genotypes and their ability to change over time, creating a one-size-fits-all vaccine is challenging. Understanding the genetic diversity of these viruses may be key to devising effective prevention strategies.
Clinical Significance
The study highlighted how RV remains a significant health concern, especially during the ongoing impact of COVID-19 and other respiratory illnesses. Continued surveillance and research into rhinoviruses will be important for public health strategies, particularly as they relate to seasonal outbreaks and potential vaccine development.
Conclusion
In summary, this research offers valuable insights into the behavior of rhinoviruses during the COVID-19 pandemic. It shows that despite efforts to control other respiratory viruses, RV continues to circulate widely, adapting and changing as it interacts with different populations. The findings underscore the need for ongoing monitoring and understanding of RV to better prepare for future health challenges.
Title: Genomic epidemiology and evolution of rhinovirus in western Washington State, 2021-22
Abstract: BackgroundHuman rhinoviruses (RV) primarily cause the common cold, but infection outcomes vary from subclinical to severe cases, including asthma exacerbations and fatal pneumonia in immunocompromised individuals. To date, therapeutic strategies have been hindered by the high diversity of serotypes. Global surveillance efforts have traditionally focused on sequencing VP1 or VP2/VP4 genetic regions, leaving gaps in understanding RV true genomic diversity. MethodsWe sequenced 1,003 RV genomes from nasal swabs of symptomatic and asymptomatic individuals to explore viral evolution during two epidemiologically distinct periods in Washington State: when the COVID-19 pandemic affected the circulation of other seasonal respiratory viruses except for RV (February - July 2021), and when the seasonal viruses reemerged with the severe RSV and influenza outbreak (November-December 2022). We constructed maximum likelihood and BEAST-phylodynamic trees to characterize intra-genotype evolution. ResultsWe detected 100 of 168 known genotypes, identified two new genotypes (A111 and C59), and observed inter-genotypic recombination and genotype cluster swapping from 2021 to 2022. We found a significant association between the presence of symptoms and viral load, but not with RV species or genotype. Phylodynamic trees, polyprotein selection pressure, and Shannon diversity revealed co-circulation of divergent clades within genotypes with high amino acid constraints throughout polyprotein. DiscussionOur study underscores the dynamic nature of RV genomic epidemiology within a localized geographic region, as more than 20% of existing genotypes within each RV species co-circulated each month. Our findings also emphasize the importance of investigating correlations between rhinovirus genotypes and serotypes to understand long-term immunity and cross-protection.
Authors: Alexander L. Greninger, S. Goya, S. T. Wendm, H. Xie, T. V. Nguyen, S. Barnes, R. R. Shankar, J. Sereewit, K. Cruz, A. C. Perez-Osorio, M. G. Mills
Last Update: 2024-02-14 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2024.02.13.24302773
Source PDF: https://www.medrxiv.org/content/10.1101/2024.02.13.24302773.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.